Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 4Burkitt Lymphoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Leukemia, Monocytic, Acute 2Leukemia 2Down Syndrome 2Neoplasms 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia, Basophilic, Acute 1

Interventions

fludarabine phosphate 4Melphalan 4Cyclophosphamide 4fludarabine 3Thiotepa 3Tacrolimus 3thymoglobulin 2blinatumomab 2Sirolimus 2Methotrexate 2Mesna 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Busulfan 2vedolizumab 1trametinib 1omipalisib 1Whole-Body Irradiation 1Vorinostat 1Transplantation 1Stem Cell Transplantation 1Rituximab 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Etoposide 1Daunorubicin 1Cytarabine 1Cyclosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Myelomonocytic, Juvenile × Daunorubicin × Clear all
NCT05656248 2026-02-04

Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
25 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡